Portfolio
As of April 30, 2020
NBPE Summary
| NBPE $ in millions, except per share | 4/30/2020 | 3/31/2020 |
| Equity Investments | $949.9 | $955.9 |
| Income Investments | 113.9 | 109.6 |
| Total Direct Investments | $1,063.8 | $1,065.4 |
| Legacy Private Equity Funds | 24.2 | 31.8 |
| Total Private Equity Fair Value | $1,088.0 | $1,097.3 |
| Cash | 122.8 | 149.6 |
| Credit Facility Borrowings | (250.0) | (250.0) |
| ZDPs | (141.0) | (138.1) |
| Dividend Payable | - | - |
| Other Assets / Liabilities (Net) | (2.9) | (14.9) |
| Net Asset Value | $816.9 | $843.8 |
| Net Asset Value Per Share | $17.47 | $18.04 |
| Capital Position | 4/30/2020 | 3/31/2020 |
| Investment Level | 133% | 130% |
| Cash + Available Credit Facility | 122.8 | 149.6 |
| Adjusted Unfunded Commitments | 123.5 | 142.0 |
| Adjusted Commitments Coverage Ratio | 99% | 105% |
| Sterling NAV & Trading Information (£) | 4/30/2020 | 3/31/2020 |
| NAV Per Share | £13.85 | £14.55 |
| Closing Share Price | £8.90 | £6.84 |
| Discount to NAV | (35.7%) | (53.0%) |
Asset Overview
TOP 10 POSITIONS BY FAIR VALUE
| Investment | Inv. Date | Industry | Fair Value ($m) | % of Value |
|---|---|---|---|---|
| ProAmpac | 2017 | Industrials | 32.6 | 3.0 |
|
|
||||
| Engineering | 2016 | TMT | 32.5 | 3.0 |
|
|
||||
| USI | 2017 | Financial Services | 32.0 | 2.9 |
|
|
||||
| Marquee Brands | 2014 | Consumer | 31.0 | 2.9 |
|
|
||||
| Business Services Company (Undisclosed) | 2017 | Business Services | 30.9 | 2.8 |
|
|
||||
| MHS | 2017 | Industrials | 29.2 | 2.7 |
|
|
||||
| LGC | 2016 | Healthcare | 27.8 | 2.6 |
|
|
||||
| Cotiviti | 2018 | Healthcare | 26.8 | 2.5 |
|
|
||||
| Action | 2020 | Consumer | 24.9 | 2.3 |
|
|
||||
| Beyond Trust | 2018 | TMT | 23.3 | 2.1 |
|
|
||||
| Total | 291.0 | 26.8 | ||
INVESTOR RELATIONS
NBPE’s Class A ordinary shares are admitted to trading on the Premium Segment of the Main Market of the London Stock Exchange
LEARN MORE